From: Urine cell-based DNA methylation classifier for monitoring bladder cancer
Ā | Discovery phase | Validation phase |
---|---|---|
Training set | Testing set | |
Ā | N bladder cancer (%) | N R-PFBC (%) |
Gender | ||
āMale | 86 (77) | 135 (78) |
āFemale | 25 (23) | 38 (22) |
Age | ||
āMean | 72 | 68 |
āRange | 39ā98 | 26ā99 |
Stage and grade | ||
āTis | 7 (6) | 13 (8) |
āTa LG | 26 (23) | 61 (35) |
āTa HG | 11 (10) | 20 12) |
āT1 LG | 20 (18) | 35 (20) |
āT1 HG | 22 (20) | 44 (25) |
ā> T2 LG | 1 (1) | ā |
ā> T2 HG | 24 (22) | ā |
Subtotals | 111 | 173 |
Ā | N control (%) | Ā |
Gender | ||
āMale | 29 (51) | ā |
āFemale | 28 (49) | ā |
Age | ||
āMean | 60 | ā |
āRange | 22ā82 | ā |
Urinary condition | ||
āBPH | 11 (19) | ā |
āUrolithiasis | 13 (23) | ā |
āIncontinence | 2 (4) | ā |
āBenign bladder disease | 1 (2) | ā |
āUrinary tract infections | 12 (21) | ā |
āNon-urological diseases | 18 (32) | ā |
Subtotals | 57 | ā |
Ā | Ā | N NR-PFBC (%) |
Gender | ||
āMale | ā | 217 (76) |
āFemale | ā | 68 (24) |
Age | ||
āMean | ā | 69 |
āRange | ā | 26ā92 |
Stage and grade previous TURBT | ||
āTis | ā | 21 (7) |
āTa LG | ā | 100 (35) |
āTa HG | ā | 53 (19) |
āT1 LG | ā | 22 (8) |
āT1 HG | ā | 82 (29) |
āT2 HG | ā | 3 (1) |
āTx LG | ā | 2 (1) |
āTx HG | ā | 2 (1) |
Subtotals | ā | 285 |
Total | 168 | 458 |